Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4172
Title: | Pre- and Post-operative determinants of transplantation-free survival after Fontan. The Australia and New Zealand experience | Authors: | Gentles, T. L. Bullock, A. Ayer, J. Alphonso, N. d'Udekem, Y. Celermajer, D. S. Poh, C. L. Cordina, R. L. Iyengar, A. J. Zannino, D. Grigg, L. E. Wheaton, G. R. |
Issue Date: | 2021 | Source: | 35 , 2021 | Journal: | IJC Heart and Vasculature | Abstract: | Background: This review identifies the predictors of late mortality and heart transplantation that remain relevant in the contemporary population of patients with a Fontan circulation, focusing on the potential impact of post-Fontan morbidities on the late outlook of these patients. Methods and Results: A total of 1561 patients who had survived the Fontan operation in Australia or New Zealand from 1975 to 2018 were included in this review. Over a median duration of 11.4 years, there was a total of 117 deaths (7%) and 32 heart transplantations (2%). Freedom from death and heart transplantation at 10, 20 and 35 years post Fontan surgery were 94% (95% CI 93–95%), 87% (95 %CI 85–90%) and 66% (95 %CI 57–78%) respectively. Being male, having an atriopulmonary Fontan, pre-Fontan atrioventricular valve intervention, or prolonged pleural effusions post Fontan were predictive of late death or heart transplantation. However, time-dependent variables such as the development of atrial arrhythmia, protein/losing enteropathy or late ventricular dysfunction were stronger predictors of the same outcome. Patients who developed a time-dependent risk factor had a freedom from death and heart transplantation rate of 54% (95 %CI 43–66) at 15 years and 44% (95 %CI 33–57) at 25 years post Fontan. However, 95% (95 %CI 91–99) of patients without any of the identified risk factors were free from death or heart transplantation rate at 25 years post Fontan. Conclusion: In conclusion, the occurrence of post-operative complications such as PLE, arrhythmia and ventricular dysfunction will likely precede the late demise of these patients.L20134565252021-07-14 | DOI: | 10.1016/j.ijcha.2021.100825 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L2013456525&from=exporthttp://dx.doi.org/10.1016/j.ijcha.2021.100825 | | Keywords: | major clinical study;male;pleura effusion;postoperative care;postoperative complication;preoperative care;protein losing gastroenteropathy;risk factor;shunt thrombosis;supraventricular tachycardia;surgical mortality;tachycardia;thoracotomy;transplant free survival;transesophageal echocardiography;warfarinadult;article;atrial fibrillation;atriopulmonary connection;Australia and New Zealand;cavopulmonary connection;clinical outcome;congenital heart disease;coronary artery bypass graft;cytogenetics;death;echocardiography;female;follow up;Fontan procedure;heart arrhythmia;heart atrioventricular valve;heart atrium flutter;heart failure;heart left ventricle failure;heart transplantation;heart ventricle function;human;length of stay | Type: | Article |
Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.